-
-
-
-
-
-
-
Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031
-
-
-
-
-
-
-
Ligand Pharma (LGND) Announces $225M Convetible Notes Offering; Approves $200M Buyback
-
-
-
-
-
-
102,026 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

